中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [152]
采集方式
OAI收割 [152]
内容类型
期刊论文 [146]
会议论文 [6]
发表日期
2024 [4]
2023 [11]
2022 [16]
2021 [9]
2020 [10]
2019 [9]
更多
学科主题
Pharmacolo... [5]
Toxicology [3]
Biochemist... [1]
Biophysics [1]
Cell Biolo... [1]
Chemistry [1]
更多
筛选
浏览/检索结果:
共152条,第1-10条
帮助
限定条件
存缴方式:oaiharvest
专题:上海药物研究所
第一署名单位
第一作者单位
通讯作者单位
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
发表日期升序
发表日期降序
Gold-catalyzed
endo
-selective Ring-opening of Epoxides and its Application in Construction of Poly-ethers
期刊论文
OAI收割
CHEMISTRY-A EUROPEAN JOURNAL, 2024, 页码: 10
作者:
Wu, Kehuan
;
Kang, Kaiwen
;
Liu, Dan
;
Zhang, Chiyue
;
Wang, Xinyu
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2024/03/25
6-endo ring-opening of epoxide
Baldwin's rules
gold-catalyzed reactions
marine ladder-like poly-ethers
Nakanishi hypothesis
A novel strategy for treating oncogene-mutated tumors by targeting tumor microenvironment and synergistically enhancing anti-PD-1 immunotherapy
期刊论文
OAI收割
CANCER COMMUNICATIONS, 2024, 页码: 5
作者:
Liu, Yingqiang
;
Tong, Linjiang
;
Zhang, Mengge
;
Zhang, Qi
;
Liu, Qiupei
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2024/03/13
Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2024, 页码: 16
作者:
Cheng, Chen
;
Ren, Chao
;
Li, Mu-zi
;
Liu, Yi-hui
;
Yao, Ren-qi
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2024/02/27
Traditional Chinese medicine
XueBiJing
sepsis
mortality
pharmacokinetic compatibility
polypharmacology
Structure-based development of potent and selective type-II kinase inhibitors of RIPK1
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 1, 页码: 319-334
作者:
Qin, Ying
;
Li, Dekang
;
Qi, Chunting
;
Xiang, Huaijiang
;
Meng, Huyan
  |  
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2024/03/06
RIPK1
Necroptosis
Type-II kinase inhibitors
Rational design
Lead optimization
Structure-activity relationship
Anti-inflammation
Preclinical drug discovery
CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice
期刊论文
OAI收割
AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 卷号: 23, 期号: 12, 页码: 1832-1844
作者:
Ma, Chen
;
Cao, Huiying
;
Sun, Zhen
;
Deng, Qiangqiang
;
Liu, Wenjing
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2024/02/27
hepatocyte transplantation
macrophages
T cells
survival
function
The claustrum-prelimbic cortex circuit through dynorphin/κ-opioid receptor signaling underlies depression-like behaviors associated with social stress etiology
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2023, 卷号: 14, 期号: 1, 页码: 17
作者:
Wang, Yu-Jun
;
Zan, Gui-Ying
;
Xu, Cenglin
;
Li, Xue-Ping
;
Shu, Xuelian
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2024/02/19
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
期刊论文
OAI收割
MOLECULAR PSYCHIATRY, 2023, 页码: 11
作者:
Zhang, Yong-mei
;
Zong, Hai-chao
;
Qi, Ying-bei
;
Chang, Liu-liu
;
Gao, Ya-nan
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2023/12/08
Deciphering the functional landscape of phosphosites with deep neural network
期刊论文
OAI收割
CELL REPORTS, 2023, 卷号: 42, 期号: 9, 页码: 23
作者:
Liang, Zhongjie
;
Liu, Tonghai
;
Li, Qi
;
Zhang, Guangyu
;
Zhang, Bei
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2023/12/08
Design, synthesis and biological evaluation of salicylanilides as novel allosteric inhibitors of human pancreatic lipase
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 卷号: 91, 页码: 11
作者:
Zhao, Yitian
;
Zhang, Min
;
Hou, Xudong
;
Han, Jiaxin
;
Qin, Xiaoya
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2023/10/17
Salicylanilide
hPL inhibitor
Structure -activity relationship
Anti -obesity
Construction of Diversified Penta-Spiro-Heterocyclic and Fused-Heterocyclic Frameworks with Potent Antitumor Activity
期刊论文
OAI收割
CHEMISTRY-A EUROPEAN JOURNAL, 2023, 页码: 7
作者:
Liu, Qi
;
Liu, Xuyi
;
Li, Yazhou
;
Zhou, Yu
;
Zhao, Linxiang
  |  
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2023/10/17
spiro
fused-heterocyclic frameworks
substrate- and pH- controlled strategies
C-H activation
[4+1] and [4+2] annulation
antitumor
indazolone